BRIEF published on 10/07/2026 at 08:26, 1 day 8 hours ago Valerio Therapeutics: Review of the First Half of 2026 Financial Results Valerio Therapeutics Etherna Acquisition Abivax Collaboration InVimmune
BRIEF published on 08/24/2026 at 08:05, 1 month 15 days ago Valerio Therapeutics Acquires Etherna and Secures Financing Valerio Therapeutics Etherna Immunotherapies RNA Therapeutics Acquisition PIPE Financing Biotech Integration
PRESS RELEASE published on 08/24/2026 at 08:00, 1 month 15 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Valerio Therapeutics announces acquisition of Etherna Immunotherapies for €30 million enterprise value and €40.25 million PIPE financing. Shareholder approval secured Acquisition Valerio Therapeutics RNA Therapeutics Etherna Immunotherapies PIPE Financing
BRIEF published on 07/16/2026 at 09:12, 2 months 23 days ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
BRIEF published on 07/16/2026 at 09:12, 2 months 23 days ago Valerio Therapeutics Partners with Abivax for RNA Therapeutics Development Biotechnology Valerio Therapeutics Pipelines RNA Therapeutics Abivax Collaboration
PRESS RELEASE published on 07/16/2026 at 09:07, 2 months 23 days ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
BRIEF published on 07/01/2026 at 09:27, 3 months 7 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 3 months 7 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
PRESS RELEASE published on 07/01/2026 at 09:22, 3 months 7 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
BRIEF published on 06/16/2026 at 19:48, 3 months 21 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
Published on 10/08/2026 at 14:31, 2 hours 25 minutes ago First Breach Expands Hiring Initiative to Support Ammunition Production Growth and Planned Drone Manufacturing Operations
Published on 10/08/2026 at 14:30, 2 hours 26 minutes ago Predictiv AI's Shift AI Completes AWS Foundational Technical Review and Expands Aviation Visibility Through AWS Solutions Library
Published on 10/08/2026 at 14:00, 2 hours 56 minutes ago Earthwise Minerals Appoints Andy Randell, P.Geo., to Board of Directors
Published on 10/08/2026 at 14:00, 2 hours 56 minutes ago Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia
Published on 10/08/2026 at 14:00, 2 hours 56 minutes ago Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
Published on 10/08/2026 at 16:40, 15 minutes ago Klöckner & Co sells Becker Group to consortium of Accura and BCB
Published on 10/08/2026 at 16:05, 51 minutes ago Duck Creek Technologies Expands Leadership to Accelerate Underwriting Innovation and EMEA Growth
Published on 10/08/2026 at 15:07, 1 hour 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/08/2026 at 15:05, 1 hour 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 10/07/2026 at 18:19, 22 hours 36 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:45, 23 hours 11 minutes ago Availability of the Pre-Q3 2026 Sales Communication
Published on 10/07/2026 at 15:54, 1 day 1 hour ago Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 08:15, 1 day 8 hours ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
